References
- Lanpher B, Brunetti-Pierri N, Lee B. Inborn errors of metabolism: the flux from Mendelian to complex diseases. Nat Rev Genet. 2006;7(6):449-59. doi: 10.1038/nrg1880.
- Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003;348(23): 2304-12. doi: 10.1056/NEJMoa025225.
- Howell RR, Terry S, Tait VF, Olney R, Hinton CF, Grosse S, et al. CDC grand rounds: newborn screening and improved outcomes. MMWR. 2012;61(21): 390-3.
- Harms E, Olgemöller B. Neonatal screening for metabolic and endocrine disorders. Dtsch Arztebl Int. 2011;108(1-2):11-21. doi: 10.3238/arztebl.2011.0011.
- Šmon A, Lampret Repič B, Žerjav Tanšek M, et al. Razširjeno presejanje novorojencev v Sloveniji. In: XXXVI. Derčevi dnevi. 2018 Jun 1–2. Ljubljana: Katedra za pediatrijo, Medicinska fakulteta, Univerza v Ljubljani, 2018.
- Chace DH. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. J Mass Spectrom. 2009;44(2):163-70. doi: 10.1002/jms.1528.
- Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003;49(11):1797–817.
- Šmon A. Opredelitev kriterijev za razširjeno presejanje novorojencev za vrojene bolezni presnove: doctoral thesis. Ljubljana: University of Ljubljana, 2018.
- Navodilo za izvajanje razširjenega presejanja novorojencev v Sloveniji. Pediatrična klinika, Univerzitetni klinični center Ljubljana. Accessed April 3rd, 2020 at: https://www.redkebolezni.si/ustanova/laboratoriji/ljubljana/sluzba-za-specialno-laboratorijsko-diagnostiko/
- Šmon A, Repič Lampret B, Grošelj U, et al. Next generation sequencing as a follow-up test in an expanded newborn screening program. Clin Biochem. 2018;52:48-55. doi: 10.1016/j.clinbiochem.2017.10.016.
- Grošelj U, Šmon A, Žerjav Tanšek M, et al. Expanded newborn screening (NBS) program in Slovenia. In: 6th Slovenian Congress of Endocrinology. Bled: ZES, 2018.
- Battelino T, Kržišnik C, Pavlin K. Early detection and follow-up of children with phenylketonuria in Slovenia. Zdrav Vestn. 1994;63(Suppl 1):25-8.
- Kržišnik C, Battelino T, Bratanič N, et al. Results of screening for congenital hypothyroidism during the ten-year period (1981–1991) in Slovenia. Zdrav Vestn. 1994;63(Suppl 1):29-31.
- Šmon A, Grošelj U, Žerjav Tanšek M, et al. Newborn screening in Slovenia. Zdr Varst. 2015;54(2):86-90. doi: 10.1515/sjph-2015-0013.
- Loeber JG. Neonatal screening in Europe: the situation in 2004. J Inherit Metab Dis. 2007;30:430-8. doi: 10.1007/s10545-007-0644-5.
- Repič Lampret B, Murko S, Žerjav Tanšek M, et al. Selective screening for metabolic disorders in the Slovenian pediatric population. J Med Biochem. 2015;34:58-63. doi: 10.2478/jomb-2014-0056.
- Harding C, LaFranchi SL, Thomas G, et al. The northwest regional newborn screening program; Oregon practicioner’s manual. 9th ed. Oregon: Oregon Health and Science University, 2010.
- Obvestilo za starše in skrbnike. Nacionalni program presejanja novorojencev za izbrane prirojene bolezni. Accessed April 3rd, 2020 at: https://www.redkebolezni.si/assets1191/wp-content/uploads/2016/05/Redke-bolezni_Obvestilo-za-starse-o-presejalnihtestih-novorojencev.pdf?x85004
- Repič Lampret B, Šmon A, Čuk V. Laboratorijska diagnostika vrojenih bolezni presnove. In: XXXVI. Derčevi dnevi. 2018 Jun 1–2. Ljubljana: Katedra za pediatrijo, Medicinska fakulteta, Univerza v Ljubljani, 2018.
- Rousseau F, Giguere Y, Berthier MT, et al. Newborn screening by tandem mass spectrometry: impacts, implications and perspectives. In: Prasain JK, editor. Tandem mass spectrometry – applications and principles. London: IntechOpen, 2012:751-76.
- Pravilnik o spremembi Pravilnika za izvajanje preventivnega zdravstvenega varstva na primarni ravni. Uradni list RS. 47/2018.
- MacReady RA, Hussey MG. Newborn phenylketonuria detection program in Massachussets. Am J Public Heal Nations Heal. 1964;54(12):2075¬–81.
- Burgard P, Cornel M, Filippo F, et al. Report on the practices of newborn screening for rare disorders implemented in member states of the European Union, candidate, potential candidate and EFTA countries. Accessed April 11th, 2019 at: http://old.iss.it/binary/cnmr/cont/Report_NBS_Current_Practices_20120108_FINAL.pdf
- Padilla CD, Therell BL. Newborn screening in the Asia Pacific region. J Inherit Metab Dis. 2007;30(4):490-506. doi: 10.1007/s10545-007-0687-7.
- Therell BL, Adams J. Newborn screening in North America. J Inherit Metab Dis. 2007;30(4):447-65. doi: 10.1007/s10545-007-0690-z.
- Osterreichisches Neugeborenen-Screening. Eine Einrichtung an der Universtitatsklinik für Kinder- und Jugendheilkunde zur Früherfassung von angeborenen Erkrankungen. Medizinische Universität Wien. Accessed April 11th, 2019 at: https://www.meduniwien.ac.at/hp/fileadmin/neugeborenenscreening/pdf/Folder_Neugeborenen_Screening_06.2018.pdf
- Deutsche Gesellschaft für Neugeborenenscreening e. V. Zielerkrankungen im Neugeborenenscreening. Accessed April 11th, 2019 at: http://www.screening-dgns.de/krankheiten.php
- Neugeborenen Screening Schweiz. Kinderspital Zurich, 2018. Accessed April 11th, 2019 at: http://www.neoscreening.ch/display.cfm/id/100552/disp_type/dmssimple/pageID/79190
- Program national de depistage neonatal. Ministere des Solidarites et de la Sante. Accessed April 11th, 2019 at: https://solidarites-sante.gouv.fr/soins-et-maladies/prises-en-charge-specialisees/maladies-rares/DNN
- Depistage neonatal des maladies metaboliques et endocriniennes. Cliniques universitaires Saint-Luc Bruxelles. Accessed April 11th, 2019 at: https://www.saintluc.be/laboratoires/activites/biologie-clinique/biochimie/depistage-neonatal.php
- Ohlsson A. Neonatal screening in Sweden and disease-causing variants in phenylketonuria, galatosemia and biotinidase deficiency. Karolinska Instituet, Stockholm, 2016. Accessed April 11th, 2019 at: https://pdfs.semanticscholar.org/08c9/51078a0bf299a3d689599ed6ac25c1a0ee20.pdf
- Statens Serum Institut. Screening for medfødte sygdomme. Accessed April 11th, 2019 at: https://www.ssi.dk/sygdomme-beredskab-ogforskning/screening-for-medfodte-sygdomme
- Health Service Executive. A practical guide to newborn bloodspot screening in Ireland. 7th edition. Dublin, 2018. Accessed April 11th, 2019 at: https://www.hse.ie/eng/health/child/newbornscreening/newbornbloodspotscreening/information-for-professionals/a-practical-guide-to-newborn-bloodspot-screening-in-ireland.pdf
- Public health England. Screening tests for you and your baby, 2017. Accessed April 11th, 2019 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/696849/Screening_tests_for_you_and_your_baby.pdf
- The Newborn Metabolic Screening Program. Your newborn baby’s blood test. New Zealand Government, 2017. Accessed April 11th, 2019 at: https://www.nsu.govt.nz/system/files/resources/your-newborn-babys-blood-text-oct17.pdf
- The Sydney children’s hospital network. NSW Newborn Screening. Accessed April 11th, 2019 at: https://www.schn.health.nsw.gov.au/find-a-service/laboratory-services/nsw-newborn-screening/disorders
- Newborn screening in Canada status report. Canadian PKU and Allied Disorders Inc., 2015. Accessed April 11th, 2019 at: https://www.raredisorders.ca/content/uploads/Canada-NBS-status-updated-Sept.-3-2015.pdf
- Newborn screening for your baby’s health. New York State Department of Health. Accessed April 11th, 2019 at: https://www.wadsworth.org/sites/default/files/WebDoc/1666822457/FYBH_English.pdf
- Therell BL, Padilla CD, Loeber JG. Current status of newborn screening worldwide: 2015. Semin Perinatology. 2015;39:171-87. doi: 10.1053/j.semperi.2015.03.002.
- Grošelj U, Tanšek MZ, Šmon A, et al. Newborn screening in Southeastern Europe. Mol Genet Metab. 2014;113:42-5. doi: 10.1016/j.ymgme.2014.07.020.
- Grošelj U, Tanšek MZ, Battelino T. Fifty years of phenylketonuria newborn screening - a great success for many, but what about the rest? Mol Genet Metab. 2014;113(1-2):8-10. doi: 10.1016/j.ymgme.2014.07.019.
- Bilandžija I, Barić I, Škaričić A, et al. Program proširenog novorodenačkog probira u Republici Hrvatskoj – zahtjevi i izazovi pravilnog uzimanja suhe kapi krvi. Peadiatr Croat. 2018;62(Suppl 1):10-4.
- Centers for Disease Control and Prevention. Using tandem mass spectrometry for metabolic disease screening among newborns. MMWR. 2001;50:1-22.
- American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group. Tandem mass spectrometry in newborn screening. Genet Med. 2000;2:267-9. doi: 10.1097/00125817-200007000-00011.
- Naylor EW, et al. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol. 1999;14(Suppl 1):S4-8. doi: doi.org/10.1177/0883073899014001021.
- Žerjav Tanšek M, Grošelj U, Murko S, et al. Assessment of tetrahydrobiopterin (BH4)-responsiveness and spontaneous phenylalanine reduction in a phenylalanine hydroxylase deficiency population. Mol Genet Metab. 2012;107(1/2):37-42. doi: 10.1016/j.ymgme.2012.07.010.
- Staudigl M, Gersting SW, Danecka DD, et al. The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response. Hum Mol Genet. 2011;20:2628-41. doi: 10.1093/hmg/ddr165.
- Karacic I, Meili D, Sarnavka V, et al. Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency. Mol Genet Metab. 2009:97;165-71. doi: 10.1016/j.ymgme.
- Matern D. Acylcarnitines. Physician’s guide to diagnosis, treatment and follow-up of inherited metabolic diseases. Berlin Heidelberg: Springer-Verlag, 2014:775-84.
- Holm IA, Agrawal PB, Ceyhan-Birsoy O, et al. The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018;18(1):225. doi: 10.1186/s12887-018-1200-1.
- Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit. 1968;65(4):281-393.